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ABSTRACT
Background and purpose Prompt recanalization of
cerebral arteries in patients diagnosed with acute
ischemic stroke is known to be associated with
a better clinical outcome. The aim of this study was
to present our initial experience regarding the efﬁcacy
and safety of the Solitaire FR as a revascularization
device.
Methods 56 consecutive patients presenting with acute
ischemic stroke underwent intra-arterial therapy using
the Solitaire FR revascularization device. Immediate
angiographic results and early clinical outcomes are
presented.
Results Solitaire FR was successful in achieving
recanalization in 50 out of 56 patients (89%) with a ﬁnal
Thrombolysis in Cerebral Infarction score $2b. Five out
of 56 patients had procedure related complications: two
asymptomatic subarachnoid hemorrhages, two
thromboembolic events and one symptomatic
intracranial hemorrhage (PH2). Thirty patients (53.5%)
demonstrated at discharge a National Institutes of Health
Stroke Scale Score of #1 or an improvement of at least
10 points from baseline, and 26 patients (46%) had
a modiﬁed Rankin Score #2.
Conclusions Solitaire FR is successful in achieving
a high rate of arterial recanalization with a low
complication rate. The Solitaire FR is a promising
thrombectomy tool with a high degree of effectiveness,
safety and ease of use.
INTRODUCTION
Prompt recanalization of an occluded cerebral
artery in the setting of acute ischemic stroke (AIS)
is correlated with good clinical outcome and
reduced mortality.
1 Intravenous administration of
ﬁbrinolytic drugs (recombinant tissue plasminogen
activator (rt-PA)) within 4.5 h of stroke onset is the
most common therapy for AIS in the occidental
world.
2 On the other hand, several studies have
demonstrated an improvement, in terms of recan-
alization rate and clinical outcome, with the use of
mechanical thrombectomy devices.
3 In spite of the
encouraging results reported by various types of
mechanical devices, none are accepted worldwide as
a standard recanalization tool.
The aim of the present study is to report the
immediate results of a series of 56 consecutive
patients treated at our institution using the Soli-
taire FR device, in the setting of AIS. The Solitaire
FR device in the European Union is CE ‘Commu-
nauté Européenne’ certiﬁed. Its use in our stroke
unit for thrombectomy was approved by the
members of our multidisciplinary stroke team and
given that this is a retrospective study, no ethics
approval was necessary.
METHODS
Patient selection
Patients were examined at admission by a senior
stroke neurologist who assessed the severity of the
neurological deﬁcit using the National Institutes of
Health Stroke Scale Score (NIHSS). Patients with
an NIHSS <8 for the anterior circulation were not
included and neither were patients with sponta-
neous NIHSS improvement. Clinical evolution was
evaluated daily during hospitalization using the
NIHSS and modiﬁed Rankin Score. Patients were
studied in the acute phase with MRI in order to
identify the extent of the ischemic lesion, with
the exception of one patient with a pacemaker
who underwent CT imaging. Diffusion weighted
imaging (DWI) was used for assessing the extent of
the ischemic lesion. MR angiography was used to
identify and locate the site of vessel occlusion. T2
and FLAIR weighted imaging was used to deter-
mine the timing of the ischemic lesions. Perfusion
imaging was used to identify the contribution of
the collateral circulation to the ischemic zone. For
patients with anterior circulation strokes, the
Alberta Stroke Program Early CT (ASPECT) score,
4
calculated on DWI,
5 was used to assess the
ischemic core. Only patients with an ASPECTscore
$5 were candidates for treatment. All inclusion/
exclusion criteria for this study are summarized in
box 1.
In accordance with our institutional stroke
protocol (table 1), patients presenting within 4.5 h
from symptom onset, secondary to an isolated M1
occlusions, were initially treated with intravenous
ﬁbrinolysis (rt-PA 0.9 mg/kg). Thrombectomy was
performed as a rescue therapy if clinical improve-
ment (NIHSS improvement of at least 4 points)
was not achieved within 60 min from the intrave-
nous injection. The efﬁcacy of intravenous therapy
alone in internal carotid artery (ICA) occlusions
is limited, as demonstrated by Linfante and
colleagues.
6 Therefore, thrombectomy was carried
out in a ‘combined approach’ if the patient
presented with ICA or tandem occlusions within
4.5 h. Patient presenting between 4.5 and 6 h with
anterior circulation strokes were treated with
thrombectomy alone. For patients with posterior
circulation strokes, a combined approach was
performed up to 24 h, depending on the extent of
the ischemic lesions and the clinical status. In the
posterior circulation, the exclusion criteria were
based on the radiological appearances on DWI.
Extensive brainstem lesionsdfor example, bilateral
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New devicescomplete involvement of the pons or diencephalic structuresd
were the main exclusion criteria.
Device
The Solitaire FR revascularization device (EV3, Irvine, California,
USA) is a stent based thrombectomy system with a closed cell
design and a longitudinal split section (ﬁgure 1). The device is
delivered through a standard microcatheter (inner lumen diam-
eter of 0.021 inches or 0.027 inches) via a 0.016 inch nitinol
pushwire. The unique Solitaire stent based design features allow
for dual functionality: ﬁrstly, it acts as a temporary intracranial
bypass providing immediate ﬂow restoration through the
thrombus; and secondly, it acts as a clot retriever, trapping
thrombus into its cells allowing for clot removal. It received CE
Mark approval as a ﬂow restoration device.
Procedure
All procedures were performed via a femoral artery approach
under general anesthesia. For the anterior circulation, an 8 Fr
or 9 Fr Merci balloon guiding catheter (Concentric Medical,
Mountain View, California, USA) was introduced through
a femoral sheath into the appropriate carotid artery. For the
posterior circulation, a 6 Fr Envoy guiding catheter (Cordis,
Miami Lake, Florida, USA) was placed into the dominant, or
navigable, vertebral artery. A 0.021 inch internal diameter
microcatheter Prowler Select Plus (Cordis) or Vasco 21 (Balt,
Montmorency, France) was navigated distal to the point of
occlusion over a 0.014 inch steerable microwire. A microcatheter
angiographic run was then carried out in order to conﬁrm and
deﬁne the vasculature distal to the thrombus. The Solitaire FR
was then introduced through the microcatheter and the device
deployed across the occluding thrombus. The microcatheter
distal marker was positioned at the exact level of the proximal
marker of the stent. An intravenous bolus of 1000 IU of standard
heparin was administered at this time. On Solitaire FR deploy-
ment, an angiographic control was performed in order to
evaluate the correct placement and expansion of the device.
After the angiographic run, the Solitaire FR was maintained in
place for a few minutes (3e7 min) to allow device expansion.
After this time, the fully deployed Solitaire FR and the delivery
microcatheter were gently pulled back together and recovered
through the guiding catheter. The Solitaire FR was at no point
completely or partially resheathed. During the retrieval, the
balloon guide catheter was inﬂated to suspend anterograde ﬂow.
Manual aspiration with a 50 ml syringe was performed through
the hemostatic valve during the retrieval in order to reverse the
ﬂow and to aspirate clot debris eventually present in the lumen
of the guide catheter. A maximum of ﬁve passes were performed
using the device, if necessary (ﬁgure 2). The integrity of the
stent was consistently checked after every pass. No additional
devices were used with the Solitaire FR and it was not used in
combination with intra-arterial rt-PA in any case.
RESULTS
From July 2009 to July 2010, 56 consecutive patients (24 men
and 32 women) aged 26e91 years (median 67.5, mean 67) were
treated with Solitaire FR in the setting of AIS (table 2). The
target vessel was the middle cerebral artery (MCA) in 27
patients. In 14 patients the occlusion involved the ICA, in nine
the intracranial carotid bifurcation (carotid T) and in ﬁve both
the cervical carotid artery and carotid T or MCA (tandem
occlusion). In 15 patients, the target artery was the basilar artery
(BA). In all patients, the presenting Thrombolysis in Cerebral
Infarction (TICI)
7 perfusion category was 0. The mean
presenting Glasgow Coma Scale, available for 35 patients, was
11 (median 11; range 3e15). The mean presenting NIHSS,
available for 49 patients, was 15.8 (median 16; range 7e26).
Mean time from stroke symptom onset to presentation to the
emergency department was 2 h and 49 min (median 124 min;
range 45e630 min). Mean time from presentation to the emer-
gency department to the baseline angiogram was 2 h and 27 min
(median 145 min; range 40e450 min).
The Solitaire FR was able to obtain complete vessel recanali-
zation with normal perfusion of the involved arterial territory
(TICI 3) in 46 patients (82%). A TICI perfusion of $2b was
obtained in 50 patients (89.2%). The highest rate of TICI $2b
was obtained in patients with MCA occlusion (92.5%; 25/27
patients). In ﬁve cases (8.9%), Solitaire FR failed to recanalize the
occluded vessel and to restore antegrade ﬂow beyond the point of
occlusion, with a ﬁnal TICI score of 0. Four of these cases (80%)
had undergone combined therapy. The occlusion sites were
localized in the carotid T for three patients and in the BA and the
M1 for the other two. ATICI score of 2a was obtained in a case of
BA occlusion. Partial recanalization (TICI 2b) was obtained in
four patients (7%). In these cases the occlusion was localized
twice in the MCA and once in the BA and the carotid T.
Box 1 Inclusion and exclusion criteria
Inclusion criteria
< Proximal major vessel occlusion: middle cerebral artery,
terminal internal carotid artery or basilar artery
< All stroke patients with a relevant deﬁcit
< Time window <6 h for the anterior circulation
< Time window <24 h for the posterior circulation
Exclusion criteria
< National Institutes of Health Stroke Scale Score (NIHSS) <8i n
middle cerebral artery occlusions
< Alberta Stroke Program Early CT (ASPECT) score <5 (anterior
circulation)
< Extensive brain stem involvement
< Spontaneous NIHSS score improvement
Table 1 Treatment strategy
0e3h 3 e4.5 h 4.5e6h >6h
MCA Rescue Rescue Mechanical
MCAeICA tandem Combined Combined Mechanical
Carotid bifurcation Combined Combined Mechanical
BA Combined Combined Combined Combined
BA, basilar artery; ICA, internal carotid artery; MCA, middle cerebral artery.
Figure 1 Solitaire FR revascularization device is a self-expanding,
nitinol system with closed cells and a longitudinal split, overlap design.
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New devicesThe mean number of passes performed per procedure was 2
(median 2; range 1e5). Mean time needed for recanalization of
the target artery, calculated from the baseline angiogram, was
37 min (median 27; range 4e236) (table 3). We observed vaso-
spasm following clot retrieval in 18 of 56 patients (32%), which
resolved after intra-arterial injection of nimodipine (intra-arteri-
ally 2 mg in 10 ml). Of the 11 patients treated with mechanical
thrombectomy alone, 10 achieved a TICI score $2b. Similarly,
in 16 of 17 patients treated with mechanical thrombectomy
following failure of intravenous treatment (rescue thrombec-
tomy),aTICIscore$2bwasobtained.Intheﬁvecasesoftandem
occlusions, theproximalobstruction wasinthreecasessecondary
to a thromboembolus and in two secondary to an atherosclerotic
plaque. In the thromboembolism cases, the guide catheter was
advanced past the proximal occlusion while aspirating. In two
cases of a signiﬁcant atherosclerotic stenosis, the catheter was
advanced distal to the proximal occlusion following balloon
angioplasty. The distal intracranial thrombosis was then treated
to re-establish the cerebral circulation as soon as possible. In one
of these patients, the carotid stenosis had to be treated acutely to
maintain adequate cerebral perfusion. In the other patient,
treatment was carried out 2 weeks following the acute phase. A
TICI score of 3 was obtained in all cases except one.
The overall rate of procedure related complication was 8.9%
(5/56 patients), as detailed below. Angiographic evidence of
thromboembolic events occurred in two cases (3.4%). The ﬁrst
thromboembolic complication occurred during basilar artery clot
retrieval through a right vertebral artery approach. Thrombus
fragmentation was the suspected mechanism of a subsequent
right posterior inferior cerebellar artery occlusion that resulted in
a cerebellar infarction. The second thromboembolic event
occurred during clot removal in a case of terminal carotid and
MCA thrombosis and consisted of an anterior cerebral artery
occlusion (ﬁgure 3).
Two procedure related but asymptomatic subarachnoid
hemorrhages were recorded (3.5%). A postprocedural intracere-
bral hemorrhage (ICH) PH2
8 (1.7%; 1/56 patients) occurred in
a patient with a left M1eM2 occlusion. In this case,
Figure 2 (A) A frontal angiogram
showing a mid-third basilar artery (BA)
occlusion. (B, C) Solitaire FR deployed
through the thrombus and allowing
partial opaciﬁcation of the BA. (D)
Following the ﬁrst pass of the Solitaire
FR, the left posterior cerebral artery
(PCA) remained occluded. (E, F) A
second pass in the left PCA resulted in
complete recanalization of the BA and
its branches (Thrombolysis in Cerebral
Infarction 3).
Table 2 Patient characteristics
Characteristic
No of patients 56
Demographic data
Age (years) (mean (range)) 67 (26e91)
Male gender (% (n)) 42 (24)
Stroke severity
NIHSS score (mean (range)) (49 patients) 15.8 (7e26)
GCS (mean (range)) (35 patients) 11 (3e15)
Site of occlusion
ICA 9 (16.0%)
MCA (M1/M2) 27 (48.2%)
Basilar artery 15 (26.7%)
Tandem 5 (8.9%)
GCS, Glasgow Coma Scale; ICA, internal carotid artery; MCA, middle
cerebral artery; NIHSS, National Institutes of Health Stroke Scale Score.
Table 3 Procedure mean time
Mean (range)
Time to presentation (min) 169 (45e630)
Baseline angiogramdTICI $2b (min) 37 (4e236)
Presentation to treatment* (min) 147 (40e450)
*Treatment time is deﬁned as the time of the ﬁrst angiographic run.
TICI, Thrombolysis in Cerebral Infarction.
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ﬁbrinolysis. Four passes of the device were performed and TICI
2b was achieved 7 h and 20 min after symptom onset. The ﬁnal
procedural angiographic control did not show contrast medium
extravasation and the postoperative CT scan did not demon-
strate any hemorrhagic event. At 24 h, the control CT showed
a large intraparenchymal hematoma in the left MCA territory.
The hematoma did not require surgical evacuation and at
discharge, the clinical score of the patient was stable (NIHSS 20).
Four patients died (7.14%; 4/56 patients) during the initial
postprocedural hospitalization. None of the deaths were directly
related to the intervention or the device.
The average postoperative NIHSS score at awaking (available
for 24 patients) was 10.5 (median 9; range 0e25). NIHSS
calculated at discharge (available for 48 patients; 65.5%) was, on
average, 7 (median 3.5; range 0e26). At discharge, 30 patients
(53.5%) presented with an NIHSS of #1 or an improvement of
at least 10 points from baseline, and 26 patients were discharged
with a modiﬁed Rankin Score of #2. Improved clinical outcome
was most frequent in patients with M1 occlusions (16 of 27
patients: 59.2%). Worse clinical outcomes was noted for patients
with BA occlusions; only ﬁve of 15 patients (33.3%) had a good
clinical outcome at discharge.
DISCUSSION
Several studies have demonstrated the efﬁcacy of a combined
intravenous and endovascular approach in the treatment of AIS
compared with intravenous therapy alone.
9 10 While the intra-
venous administration of ﬁbrinolytic drugs is easy to perform
and to reproduce, the feasibility of the endovascular mechanical
approach is widely variable, depending on different institutional
protocols, operators and devices used. Numerous endovascular
techniques and thrombectomy devices have been used over the
years.
Thrombectomy tools are subdivided in proximal and distal
devices, depending on where they apply force to the thrombus.
Furthermore, there are a number of other devices used off-label
for recanalizationdthat is, temporary occlusion balloons, self-
expanding intracranial stents and balloon mounted coronary
stents.
11 12
Clinical experiences in using MERCI Retriever device
(Concentric Medical) have been extensively reported. In the
Multi-MERCI trial,
13 a recanalization rate of 69.5% (91/131
patients)wasobtainedwhenthrombectomywasassociatedwith
postadjunctive intra-arterial administration of ﬁbrinolytic drugs.
Symptomatic ICH occurred in 9.8% of patients (16/131 patients)
and clinically signiﬁcant intraprocedural complications were
reported in 5.5% of cases (9/131 patients). The mean number of
passes performed per intervention was 2.9. The results of this
series, compared with our results, show a lower rate of target
vessel recanalization (65.5% vs 89.2%), a higher number of passes
per procedure (2.9 vs 2), a higher rate of clinically signiﬁcant
intraprocedural complications and symptomatic hemorrhages.
The investigators from the Penumbra Pivotal Stroke Trial
14
reported on 125 acute stroke patients treated with the Penumbra
System (Penumbra Inc, Alameda, California, USA). In this series,
81.6% of the target vessels were recanalized to TIMI 2e3.
Eighteen procedural events in 16 patients (12.8%) were reported.
Total mortality was 32.8%, and 35 patients (28%) were found to
have ICH on 24 h CT, of which 14 (11.2%) were symptomatic.
At 90 days, 25% of the patients achieved a modiﬁed Rankin Scale
score of #2. Paradoxically, for a proximal thrombectomy device
(compared with a distal device) the Penumbra System demon-
strated a higher rate of ICH compared with our study. Moreover,
the 90 day follow-up of the Penumbra trial cohort (25% of
patients with a modiﬁed Rankin Scale score of #2) did not
correlate with the high incidence of target artery recanalization
(81.6%) reported. This is most likely secondary to the TIMI
scoring system used by the investigators to evaluate the degree
of recanalization which is not directly related to the degree of
arterial bed reperfusion distal to the occlusion and hence clinical
recovery.
Intracranial self-expanding microstents have been used
successfully as temporary or permanent endovascular bypass
in the invasive management of AIS.
15 With this technique
the stent deployed at the point of vessel occlusion expands,
displacing circumferentially the thrombus and allowing ﬂow
restoration. The re-establishment of ﬂow through the occlusion
site promotes immediate dissipation of prothrombotic factors. At
the same time, the restored arterial ﬂow allows for thrombolytic
medications to be in contact with thrombotic material trapped
within the mesh of the stent and against the arterial wall.
Recently, Castano et al
16 reported their experience using the
Solitaire AB stent (EV3), the version of the Solitaire stent
Figure 3 A thromboembolic occlusion
of the right anterior cerebral artery
(ACA) occurred during clot removal
from the ipsilateral carotid termination.
(A) Initial frontal angiogram showing
a right terminal carotid occlusion. (B)
Solitaire FR deployed through the
thrombus allowed immediate ﬂow
restoration. (C) After Solitaire FR
retrieval, the thrombus is removed from
the occlusion site. (D, E) Diffusion
weighted imaging before and after the
procedure shows an extension of
ischemic lesion in the right ACA
territory.
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device in the treatment of 20 patients presenting within 8 h of
stroke symptom onset. The authors described a procedural
technique very similar to what we use. Although they only
included anterior circulation stroke cases, the results are
comparable with ours in terms of recanalization rate (90% vs
89.2%), early good clinical outcome (50% vs 53.5%) and number
of device passes performed per procedure (1.4 vs 2).
In our experience, the Solitaire FR was used as the primary
recanalization device in a consecutive series of 56 AIS patients.
From a technical point of view, the Solitaire FR was easily
navigated to the occlusion point and its deployment across the
thrombus was obtained in every case at ﬁrst attempt. No device
fractures were recorded in our series.
One can imagine that retrieval of the stent fully deployed
would be dangerous in term of vessel damage. We did not
experience any cases of vessel dissection. Jahan,
17 on a swine
model, demonstrated no problems angiographically and micro-
scopically, with vessel dissection following use of the Solitaire
FR. However, he observed vasospasm, as in a number of our
patients, following clot retrieval. Following the off-label use of
the Solitaire FR in the M2 and M3 segments to retrieve distal
emboli secondary to the initial thrombectomy, we observed two
cases of asymptomatic subarachnoid hemorrhage. One symp-
tomatic case of ICH (PH2) was reported. Furthermore, the most
important was the use of a balloon mounted guiding catheter
for thrombus removal. On multiple occasions, thrombus was
found in the 50 ml syringe used for manual aspiration during
device retrieval. It is possible that the stent in these cases just
facilitated clot retrieval by displacing and mobilizing the
thrombus.
This was a single center, non-randomized, retrospective study
with a small number of patients. But this was a consecutive
series and all patients from July 2009 to July 2010 were included.
In our results, we did not differentiate between anterior and
posterior circulation lesions. However, studies have shown that
outcome in the posterior fossa is not as favorable.
The true indicator of a successful intervention or therapy is
good long term clinical outcome. In this article, we have
reported technical notes and data regarding immediate clinical
results using the Solitaire FR. We plan to follow-up these
patients and correlate their long term clinical evolution with the
initial MR imaging data, in particular with perfusion and
diffusion sequences.
CONCLUSION
Based on our initial experiences with the Solitaire FR throm-
bectomy system, we postulate that it is a valid tool in the
treatment of AIS, providing effective, safe and rapid arterial
recanalization. Our limited initial results must be followed-up
and compared with larger series and long term clinical outcome
data.
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Key messages
< Prompt recanalization of an occluded cerebral artery in the
setting of acute ischemic stroke (AIS) is correlated with good
clinical outcome and reduced mortality.
< Intravenous administration of ﬁbrinolytic drugs is the most
common therapy for AIS.
< Mechanical thrombectomy devices compared with intrave-
nous ﬁbrinolysis, provide an improved recanalization rate and
clinical outcome.
< The Solitaire FR revascularization device is a stent based
thrombectomy system with a closed cell design and
a longitudinal split section.
< In 56 consecutive AIS patients, the Solitaire FR achieved
a high rate of arterial recanalization with a low complication
rate.
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